(Q35568545)

8 August 2017

1 reference

title

The management of oromandibular motor disorders and facial spasms with injections of botulinum toxin (English)

1 reference

8 August 2017

Glenn T. Clark

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14580034

25 March 2024

language of work or name

1 reference

1 November 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1047965103000445?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1047-9651(03)00044-5

https://api.elsevier.com/content/article/PII:S1047965103000445?httpAccept=text/plain

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1047-9651(03)00044-5

Physical medicine and rehabilitation clinics of North America

25 March 2024

published in

1 reference

8 August 2017

volume

14

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

727-748

1 reference

Treatment of bruxism with botulinum toxin injections

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Bruxism after brain injury: successful treatment with botulinum toxin-A.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Treating severe bruxism with botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Treatment of severe post-traumatic bruxism with botulinum toxin-A: case report

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

The medical management of masseteric hypertrophy with botulinum toxin type A

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin treatment of bilateral masseteric hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Unilateral temporalis muscle hypertrophy managed with botulinum toxin type A

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Jaw closing spasm--a form of focal dystonia? An electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin A for trismus in cephalic tetanus

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin A is effective in treating trismus associated with postradiation myokymia and muscle spasm

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Recurrent trismus and stridor in an ALS patient: successful treatment with botulinum toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Hemimasticatory spasm: clinical and electrophysiologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Hemimasticatory spasm in hemifacial atrophy: diagnostic and therapeutic aspects in two patients

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Hemimasticatory spasm associated with localized scleroderma and facial hemiatrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Customized EMG needle insertion guide for the muscle afferent block of jaw-deviation and jaw-opening dystonias.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Nonsurgical treatment of platysmal bands with injection of botulinum toxin A

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum A exotoxin for the management of platysma bands

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin injection for the treatment of oromandibular dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin injections for lingual dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Tongue protrusion dystonia: treatment with botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Anaesthesia and pain management in cerebral palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Tics in Tourette syndrome: new treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin in the treatment of tics

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Treatment of relative sialorrhoea with botulinum toxin type A: description and rationale for an injection procedure with case report

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Hemifacial spasm: clinical findings and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin for blepharospasm and hemifacial spasm: stability of duration of effect and dosage over time.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Cross-correlation between stress, pain, physical activity, and temporalis muscle EMG in tension-type headache

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

Remote F-wave changes after local botulinum toxin application

1 reference

https://api.crossref.org/works/10.1016%2FS1047-9651%2803%2900044-5

7 January 2021

The medical management of masseteric hypertrophy with botulinum toxin

10

1 reference

https://api.crossref.org/works/10.1016/S1047-9651(03)00044-5

Botulinum toxin treatment of essential palatal myoclonus tinnitus

25 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/S1047-9651(03)00044-5

Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm

25 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/S1047-9651(03)00044-5

Botulinum toxin treatment in patients with facial synkinesis

25 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/S1047-9651(03)00044-5

Temporomandibular dysfunction, chronic orofacial pain and oral motor disorders in the 21st century

25 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/S1047-9651(03)00044-5

25 March 2024

Identifiers

1 reference

8 August 2017

1 reference